Current Oncology Reports

Article	Citations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	137
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	135
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	89
New Developments in VHL-Associated Neuroendocrine Neoplasms	89
Management of Upper Tract Urothelial Carcinoma	83
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	74
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	70
Brain Prehabilitation for Oncologic Surgery	66
Immunotherapy in Biliary Tract Cancers: Where Are We?	58
NRG1 Fusions: The New Kid on the Block	54
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	51
New Insights on Tramadol and Immunomodulation	50
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	43
Fatty Acid Metabolism and Cancer Immunotherapy	41
Treatment of Metastatic Melanoma in the Elderly	41
Surgical Management of Melanoma: Advances and Updates	37
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	37
Prostate Cancer Immunotherapy—Finally in From the Cold?	35
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	35
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	35
Management of In-Transit Metastases	35
Current Trends and Challenges of Microbiome Research in Prostate Cancer	35
An Overview of Angiogenesis in Bladder Cancer	34
Head and Neck Mucosal Melanoma: Where Are We Now?	32
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	31

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	31
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	31
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	31
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	31
Cellular Therapy in NSCLC: Between Myth and Reality	31
Anti-PD-1: When to Stop Treatment	30
The Microbiome in Advanced Melanoma: Where Are We Now?	29
Engineered T Cells: CAR T Cell Therapy and Beyond	28
The Difficult Airway in Patients with Cancer	28
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	27
AXL Inhibitors: Status of Clinical Development	27
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	27
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review	26
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours	25
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations	25
Cancer Pain Management—New Therapies	25
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	24
Proton Therapy in The Treatment of Head And Neck Cancers- Review	24
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors	24
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?	24
Appendiceal Neuroendocrine Neoplasms: an Update for 2023	24
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	24
Targeting the PI3K Pathway in Gynecologic Malignancies	24
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations	23
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews	23
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases	23
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question	23
Surgery for Recurrent Epithelial Ovarian Cancer	22
Geographical Disparities in Colorectal Cancer in Canada: A Review	22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma	22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review	21
Development of Effective Siglec-9 Antibodies Against Cancer	21
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies	21
Helping Patients Understand and Cope with BRCA Mutations	21
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer	21
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	20
Vascular Inflammation, Cancer, and Cardiovascular Diseases	20
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer	20
Current Management of Neuroendocrine Tumour Liver Metastases	20
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials	20
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions	20
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing	20
Evolving Treatment Approaches to Mucosal Melanoma	19
Elderly Rectal Cancer: An Updated Review	19
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging	19
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia	19
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets	18
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction	18
Small Cell and Other Rare Histologic Types of Cervical Cancer	18
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?	18

Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions	17
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management	17
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic	17
Management of Peripheral T-cell Lymphomas and the Role of Transplant	17
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer	17
Ependymoma: Evaluation and Management Updates	17
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity	17
Current Diagnostic Tools for Breast Cancer-Related Lymphedema	17
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review	16
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review	16
Current Status on Management of Primary Plasma Cell Leukemia	16
Multimodality Therapies for Localized Prostate Cancer	16
History of Leukemia, Revisited	16
Intratumoral Immunotherapy: Is It Ready for Prime Time?	16
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights	16
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review	16
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives	15
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities	15
Epidemiology of Cancer in Older Adults: A Systematic Review	15
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers	15
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy	15
Statins for Cardiac and Vascular Protection During and After Cancer Therapy	15
Return to Intended Oncological Therapy: State of the Art and Perspectives	14
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy	14
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions	14
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours	14
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	14
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment	14
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis	14
Richter’s Transformation	14
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade	14
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma	14
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge	14
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	13
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas	13
Carbon Ion Radiotherapy in the Head and Neck Cancers Treatment and its Potential Role in Personalized Treatment Approach– A Review of the Current Knowledge	13
Bystander effect of antibody–drug conjugates: fact or fiction?	13
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?	13
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer	13
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies	13
Viral and Clinical Oncology of Head and Neck Cancers	13
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL	13
Approaches to Non-Muscle-Invasive Bladder Cancer	12
The Role and Impact of Minimal Residual Disease in NSCLC	12
Is Myelodysplasia a Consequence of Normal Aging?	12
Lymphatic Interventions in the Cancer Patient	12
Interventional Strategies in Cancer-induced Cardiovascular Disease	12
Racial Disparities in Breast Cancer: from Detection to Treatment	12
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer	12
Current Role of Functional Imaging in the Management of Lymphoma	12
CDK4/6 inhibitors: The Devil is in the Detail	12
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations	12
Clinicopathological Review of Micropapillary Urothelial Carcinoma	12
Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review	12
Advances in Treatment of Waldenström Macroglobulinemia	11
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway	11
Cardio-Oncology in Childhood: State of the Art	11
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers	11
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism	11
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes	11
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis	11
CAR T-cell Therapy for Central Nervous System Lymphoma	11
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine	11
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan	11
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer	11
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer	11
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity	11
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab	11
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer	11
Navigating the Cancer Screening Decision for Patients with Dementia	11
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	11
Surviving Burnout as an Oncologist	11
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes	11
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment	11
Fertility-Sparing and Less Radical Surgery for Cervical Cancer	10
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	10
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors	10
Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy	10
Integrative Geriatric Oncology: A Review of Current Practices	10
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors	10

Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies	10
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner	10
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy	10
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review	10
Next-Generation Immunotherapy Approaches in Melanoma	10
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock	10
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy	9
Progress in Gynecologic Cancers with Antibody Drug Conjugates	9
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management	9
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient	9
Cytokines: Signalling Improved Immunotherapy?	9
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview	9
Correction to: Postmastectomy Functional Impairments	9
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm	9
Managing Pain and Discomfort in Children with Cancer	9
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy	9
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives	9
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?	9
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?	9
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle	9
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions	9
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?	8
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success	8
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry	8
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies	8
Disparities in Lung Cancer Treatment	8
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors	8
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients	8
Melanoma in Pediatric and Young Adult Patients	8
WEE1 Inhibitor: Clinical Development	8
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges	8
The Microbiome’s Influence on Head and Neck Cancers	8
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis	8
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach	8
Targeting Apoptosis in Cancer	8
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	8
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder	8
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths	8
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review	8
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions	8
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer	8
Asparaginase: How to Better Manage Toxicities in Adults	8
COVID-19 in Children with Cancer	8
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism	8
Germline Mutations and Ancestry in Prostate Cancer	8
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	8
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy	8
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?	8
Hairy Cell Leukemia: Where Are We in 2023?	8
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies	7
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival	7
Approach to Oligometastatic Cancer in the Elderly Patient	7
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients	7
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	7
Plant Terpenoids in Combination with Conventional Therapeutics in Colorectal Cancer: A Promising Option	7
Liver Cancer Etiology: Old Issues and New Perspectives	7
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	7
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors	7
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside	7
Chemokine Receptor Antagonists: Role in Oncology	7
Recent Progress in Mind–Body Therapies in Cancer Care	7
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients	7
Radiation and Melanoma: Where Are We Now?	7
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	7
Targeted Therapy for Melanomas Without BRAF V600 Mutation	7
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma	7
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors	7
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?	7
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges	6
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma	6
Treatment Strategy for Elderly Patients with Soft Tissue Sarcoma	6
Translocations and Gene Fusions in Sinonasal Malignancies	6
Existing Health Inequities in the Treatment of Advanced and Metastatic Cancers	6
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma	6
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	6
Update on Percutaneous Ablation for Sarcoma	6
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review	6
Current Trends and Challenges of Microbiome Research in Bladder Cancer	6
Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments	6
Immune-Related Adverse Events in Patients with Lung Cancer	6
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status	6
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	6
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)	6
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment	6
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care	6
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management	6
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment	6
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned	6
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence	6
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation	6
Palliative Care in Paediatric Oncology: an Update	6
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines	6
Dealing with Family Conflicts in Decision-making in End-of-Life Care of Advanced Cancer Patients	5
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors	5
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic	5